Editor's Choice - Variation in Intact Abdominal Aortic Aneurysm Repair Outcomes by Country: Analysis of International Consortium of Vascular Registries 2010 - 2016.


Journal

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
ISSN: 1532-2165
Titre abrégé: Eur J Vasc Endovasc Surg
Pays: England
ID NLM: 9512728

Informations de publication

Date de publication:
07 2021
Historique:
received: 03 08 2020
revised: 17 03 2021
accepted: 31 03 2021
pubmed: 20 6 2021
medline: 21 8 2021
entrez: 19 6 2021
Statut: ppublish

Résumé

Outcomes for intact abdominal aortic aneurysm (AAA) repair vary over time and by healthcare system, country, and surgeon. The aim of this study was to analyse peri-operative mortality for intact AAA repair in 11 countries over time and compare outcomes by gender, age, and geographical location. Prospective data on primary repair of intact AAA were collected from 11 countries through the International Consortium of Vascular Registries (ICVR) and analysed for two time periods, 2010 - 2013 and 2014 - 2016. The primary outcome was peri-operative mortality after endovascular aneurysm repair (EVAR) and open surgical repair (OSR). Multivariable logistic regression models were used to adjust for differences in patient characteristics. A total of 103 715 patients were included. The percentage of patients undergoing EVAR increased from 63.6% to 71.2% (p < .001) over the study period. This proportion varied by country from 35% in Hungary to 81% in the United States. Overall peri-operative mortality decreased from 2.1% to 1.6 % (p < .001). Mortality also declined significantly over time for both OSR 4.2% to 3.6 % (p = .002) and EVAR 1.0% to 0.7% (p = .002). Mortality was significantly higher for female than male patients (3.0% vs. 1.6% p < .001). The percentage of patients > 80 years old undergoing AAA repair remained constant at 23.6% (p = .91). Peri-operative mortality was higher for patients > 80 years than for those < 80 years old (2.7% vs. 1.6% p < .001). Forty-six per cent (n = 275) of all EVAR deaths occurred in the over 80s. The proportion of AAA repairs performed using EVAR has increased over time. Peri-operative mortality continues to decline for both OSR and EVAR. Outcomes however were significantly worse for both women and those aged over 80, so efforts should be focused on these patient groups to further reduce elective AAA mortality rates.

Identifiants

pubmed: 34144883
pii: S1078-5884(21)00295-1
doi: 10.1016/j.ejvs.2021.03.034
pii:
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

16-24

Subventions

Organisme : FDA HHS
ID : U01 FD006936
Pays : United States
Organisme : FDA HHS
ID : U01 FD005478
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2021 European Society for Vascular Surgery. All rights reserved.

Auteurs

Jonathan R Boyle (JR)

Cambridge Vascular Unit, Cambridge University Hospitals NHS Trust & Department of Surgery, University of Cambridge, Cambridge, UK. Electronic address: jonboyle@doctors.org.uk.

Jialin Mao (J)

Healthcare Policy and Research, Weill Cornell Medical College, New York, NY, USA.

Adam W Beck (AW)

Division of Vascular Surgery and Endovascular Therapy, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Maarit Venermo (M)

Department of Vascular Surgery, Helsinki University Hospital, Helsinki, Finland.

Art Sedrakyan (A)

Healthcare Policy and Research, Weill Cornell Medical College, New York, NY, USA.

Christian-Alexander Behrendt (CA)

Department of Vascular Medicine, Working Group GermanVasc, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Zoltan Szeberin (Z)

Department of Vascular Surgery, Semmelweis University, Budapest, Hungary.

Nikolaj Eldrup (N)

Department of Vascular Surgery, Rigshospitalet, Copenhagen University, Copenhagen, Denmark.

Marc Schermerhorn (M)

Division of Vascular Surgery and Endovascular Therapy, Beth Israel Deaconess Medical Centre, Boston, MA, USA.

Barry Beiles (B)

Australasian Vascular Audit, Australasian Society for Vascular Surgery, Melbourne, Australia.

Ian Thomson (I)

Department of Surgery, University of Otago, Dunedin, New Zealand.

Kevin Cassar (K)

Department of Surgery, Faculty of Medicine and Surgery, University of Malta, Malta.

Martin Altreuther (M)

Department of Vascular Surgery, St. Olavs Hospital, Trondheim, Norway.

Sebastian Debus (S)

Department of Vascular Medicine, Working Group GermanVasc, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.

Amundeep S Johal (AS)

The Clinical Effectiveness Unit, The Royal College of Surgeons of England, 35-43 Lincoln's Inn Fields, London, United Kingdom.

Sam Waton (S)

The Clinical Effectiveness Unit, The Royal College of Surgeons of England, 35-43 Lincoln's Inn Fields, London, United Kingdom.

Salvatore T Scali (ST)

University of Florida College of Medicine, Division of Vascular Surgery & Endovascular Therapy, Gainesville, FL, USA.

David A Cromwell (DA)

The Clinical Effectiveness Unit, The Royal College of Surgeons of England, 35-43 Lincoln's Inn Fields, London, United Kingdom.

Kevin Mani (K)

Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH